Rezolute (RZLT) Treasury Shares (2013 - 2026)

Rezolute's (RZLT) quarterly Treasury Shares came in at $2.3 million in Q1 2026, up 188.78% year-on-year from $788500.0 in Q1 2025, and down 13.01% quarter-over-quarter from $2.6 million in Q4 2025.

Rezolute (RZLT) Treasury Shares (2013 - 2026) Analysis & Trends

Rezolute has disclosed Treasury Shares across 9 years of filings, most recently posting $2.3 million for Q1 2026.

  • Treasury Shares for Q1 2026 came in at $2.3 million, up 188.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (up 188.78% YoY), and the FY2025 annual result was $1.1 million, changed N/A from the prior year.
  • Treasury Shares came in at $2.3 million for Q1 2026 at Rezolute, down from $2.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.6 million in Q4 2025 to a low of $788500.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 700,000.00
9 Abivax 91.96 Bn 91.96 Bn - -
10 Rezolute 520.13 Mn 520.13 Mn - 2.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.28 Mn
Mar 31, 2026 2.28 Mn
Dec 31, 2025 2.62 Mn
Dec 31, 2025 2.62 Mn
Sep 30, 2025 1.08 Mn
Sep 30, 2025 1.08 Mn
Jun 30, 2025 1.06 Mn
Jun 30, 2025 1.06 Mn
Mar 31, 2025 788,500.00
Mar 31, 2025 788,500.00
Mar 31, 2019 46.39 Mn
Mar 31, 2019 46.39 Mn
Dec 31, 2018 45.67 Mn
Dec 31, 2018 45.67 Mn
Sep 30, 2018 45.65 Mn
Sep 30, 2018 45.65 Mn
Jun 30, 2018 45.64 Mn
Jun 30, 2018 45.64 Mn
Mar 31, 2018 34.01 Mn
Mar 31, 2018 34.01 Mn